@article{a71c47cb2dc84b2a9870a4b17501c825,
title = "Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5",
abstract = "The majority of reproductive-age women with cardiovascular disease are sexually active. Early and accurate counseling by the cardiovascular team regarding disease-specific contraceptive safety and effectiveness is imperative to preventing unplanned pregnancies in this high-risk group of patients. This document, the final of a 5-part series, provides evidence-based recommendations regarding contraceptive options for women with, or at high risk for, cardiovascular disease as well as recommendations regarding pregnancy termination for women at excessive cardiovascular mortality risk due to pregnancy.",
keywords = "LARC, abortion, contraception, intrauterine device, pregnancy",
author = "{American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group} and Lindley, {Kathryn J.} and {Bairey Merz}, {C. Noel} and Davis, {Melinda B.} and Tessa Madden and Ki Park and Bello, {Natalie A.}",
note = "Funding Information: Dr. Bairey Merz has served on the Board of Directors for iRhythm; and has received personal fees paid through CSMC from Abbott Diagnostics and Sanofi. Dr. Madden has served on a data safety monitoring committee for Phase 4 studies of Bayer contraceptive products. Dr. Bello is supported by the National Institutes of Health/National Heart, Lung, and Blood Institute (K23 HL136853-03, R01 HL153382-01). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} 2021 American College of Cardiology Foundation",
year = "2021",
month = apr,
day = "13",
doi = "10.1016/j.jacc.2021.02.025",
language = "English",
volume = "77",
pages = "1823--1834",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
number = "14",
}